Engaging stakeholders along health technology assessment pathways: a scoping review of international practice.

ABSTRACT:

Objectives

Health technology assessment (HTA) has been characterized as a complex adaptive system that centrally features stakeholder interactions. This article provides an overview of current practices in HTA stakeholder engagement concerning medicines.

Methods

We conducted a scoping review of English-language sources published between 2018 and 2023, including 66 peer-reviewed articles and 264 gray literature sources describing stakeholder involvement in HTA processes relating to medicines.

Results

Industry is commonly permitted to provide a submission for funding, though the modes and time points of industry engagement are many. Clinician and patient engagement are regarded as especially important with increased intervention complexity and innovation. Stakeholder en

SUBMITTER: Carter D 

PROVIDER: S-EPMC12516622 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature